KalVista Pharmaceuticals (KALV)

[Value_Investor]

Liquidation for all the CBYL shareholders is the safest way to get 100% or more quick return! But the two New drugs could reward CYBL shareholders 1000% or more return in the short term should anything positive kick in from the coming Spring...

Just ask yourself a quick question: why in the hell would the majority CYBL shareholders support this deal if that deal is a worse choice for them? Unless over 50% of CBYL shareholders vote against the deal to choose the liquidation the coming merger seems inevitable...

The key point here is: how much that two New drugs really worth now? If they worth $200M or more then we actually made a good deal! Currently they worth about $150M from the deal. If they worth less than $150M then the CEO of CBYL had made a unfair deal for us! Cash value is not the only parameter to measure if that deal is fair or not since CBYL is mergering into a company with two New drugs...